Comorbidities
This subsection of the Clinical Guide explains diagnosis and treatment of LTBI in persons with HIV, iatrogenic immunosuppression, liver disease, kidney disease, diabetes, and substance use disorders. National Society of Tuberculosis Clinicians and National Tuberculosis Coalition of America, 2025: 64-73.
Treating LTBI in Special Situations
This self-paced, online course consists of interactive case-based modules that guide the participant through eight topic areas: contact to drug-resistant TB, hepatitis, HIV/AIDS, infants and children, pregnancy, renal failure, TNF-antagonists, and transplantation. The course also includes five reference books. Southeastern National TB Center, 2014.
Diabetes
TB and Diabetes: Double Trouble
This one-hour webinar explores the intricate relationship between TB and diabetes. It covers the epidemiological ties between these two diseases and provides evidence-based strategies for the prevention and management of TB in patients with diabetes. Mayo Clinic Center for TB, 2024.
HIV
Navigating TB and HIV Co-Infection
This 45-minute webinar provides an in-depth exploration of the complex relationship between TB and HIV, two infections that frequently intersect with profound clinical implications. Mayo Clinic Center for TB, 2024.
HIV and TB: A Tale of 2 Epidemics
This one-hour webinar gives an overview of the current state of TB-HIV coinfection. A review of the most current research is provided to support appropriate diagnosis and treatment of persons with TB and HIV. Mayo Clinic Center for TB, 2023.
Treatment of TB in Adults with HIV Infection
To assist clinicians in managing LTBI and TB in HIV-infected patients, this pocket reference includes guidelines for the diagnosis and treatment of LTBI and TB and includes adult dosing, available dosage forms, drug-drug interactions, side effects and important patient counseling points. AETC Southeast and the Southeastern National TB Center, 2023.
Limiting Liver Toxicity in the HIV-Positive Patient with LTBI
This trifold brochure is intended to assist in the identification and management of hepatotoxicity in HIV/TB coinfected patients being treated for LTBI. The brochure contains information on LTBI in the context of HIV: hepatotoxicity, toxicity monitoring, and screening guidelines. Heartland National TB Center, 2021.